14.00

Welcome

Prof. Kurt Zatloukal - Project Coordinator - Director - Diagnostic and Research Institute of Pathology - Medical University of Graz – Austria

Alexandru Padurean – Project Officer – HaDEA – EU Commission

14.10

Addresses of MEPs

Vlad Voiculescu – Romania – RENEW Europe

Dan Barna – Romania – RENEW Europe

Aldo Patriciello – Italy – Patriots for Europe

14.20

Session 1 – Medical need of NGS and precision diagnostics in cancer care

Moderator

Prof. Ruth Ladenstein - Senior Consultant in Paediatric Oncology - St. Anna Children’s Cancer Research Institute - Austria, Coordinator ERN PaedCan - Board Member SIOP Europe 

Speaker

Prof. Giuseppe Curigliano - Department of Oncology and Hemato-Oncology - University of Milano La Statale - Clinical Director - Division of Early Drug Development - European Institute of Oncology, IRCCS - Milan - Italy

Panel Discussion

Dr. Giovanni Apolone - President & Chairperson OECI EU Affairs - Scientific Director Foundation IRCCS - Istituto Nazionale dei Tumori - Milan - Italy

Dr. Marc van den Bulcke PhD - Head of Service – Sciensano - Belgium

Prof. Paolo Casali - Director Medical Oncology Unit 2 - & Secretary of the Ethics Committee - Istituto Nazionale - Milan - Italy - Project Coordinator of Joint Action On Networks of Expertise on Cancer - Board Member ESMO

Prof. Francesco de Lorenzo - President F.A.V.O. - Italian Federation of Volunteer Cancer Patient Organisations

Prof. Klaus Pantel - Director of Institute of Tumor Biology - University Hospital Eppendorf (UKE) - University of Hamburg - Germany 

Open Floor and Wrap Up

15.20

Session 2: How can innovative technologies meet regulatory requirements for in vitro diagnostics and how European standards can help

Moderator

Prof. Kurt Zatloukal - Project Coordinator - Director - Diagnostic and Research Institute of Pathology - Medical University of Graz - Austria

Speaker

Innovative Workflow Technologies and European Standards meet Regulatory Requirements

Dr. Uwe Oelmüller - Vice President, Head of the Molecular Diagnostics Technology Center for Sample Technologies - QIAGEN GmbH – Germany

Panel Discussion

Niklas Blomberg – Executive Director -IHI Innovative Health Initiative

Francesca Fenizia – Executive Director IQNPath

Flora Giorgio - Head of Unit Medical Devices D3 -DG Sante TBC

Matthijs van Meerveld -EFPIA Oncology Platform Representative - Associate Vice President - Global Head of Access Policy & Patient Advocacy - Oncology Dept. – Menarini

Jesus Rueda Rodriguez - Director-General of Strategies and Special Projects – MedTech

Open Floor and Wrap Up

16.20

Coffee Break

Session 3: Health economic benefits of NGS as prerequisite for reimbursement schemes. How to overcome inequalities for patients in accessing precision diagnostics in Europe

Moderator

Prof. Wim van Harten - Research Group Leader - The Netherlands Cancer Institute, Amsterdam - Chair Working Group Health Economics, OECI - (em) Professor Quality Management and Health Care Technology

Speaker

Panel Discussion

Dr. Marc van den Bulcke PhD - Head of Service - Sciensano - Belgium

Prof. Fortunato Ciardiello - Director - Division of Medical Oncology - Dean of the School of Medicine and Surgery - University of Campania Luigi Vanvitelli - Naples 

Francesco Florindi - Policy Officer - DG Research & Innovation - Unit D2 Health Innovations & Ecosystems - Brussels - Belgium

Prof. Jose M. Martin-Moreno - Preventive Medicine and Public Health - University of Valencia - Spain

Prof. Lotte Steuten - Deputy Chief Executive - Office of Health Economics

Open Floor and Wrap Up

Conclusions

Cocktail Reception